截至10月31日，利民股份股东户数6.25万，较上期增加12.55%；人均流通股6444股，较上期减少 11.15%。2025年1月-9月，利民股份实现营业收入35.99亿元，同比增长7.62%；归母净利润3.90亿元，同 比增长661.66%。 分红方面，利民股份A股上市后累计派现9.18亿元。近三年，累计派现3.21亿元。 责任编辑：小浪快报 今年以来利民股份已经6次登上龙虎榜，最近一次登上龙虎榜为6月20日，当日龙虎榜净买入2477.86万 元；买入总计1.69亿元 ，占总成交额比9.30%；卖出总计1.44亿元 ，占总成交额比7.94%。 资料显示，利民控股集团股份有限公司位于江苏省新沂经济开发区经九路69号，成立日期1996年12月17 日，上市日期2015年1月27日，公司主营业务涉及农用杀菌剂原药及制剂的研发、生产和销售。主营业 务收入构成为：农用杀菌剂50.57%，农用杀虫剂30.51%，兽药9.34%，农用除草剂8.47%，其他0.96%， 其他农药0.15%。 利民股份所属申万行业为：基础化工-农化制品-农药。所属概念板块包括：生物农药、合成生物、锂电 池、小盘、固态电池等。 11月14日 ...

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has shown significant stock performance, with a year-to-date increase of 154.18% and a recent rise of 2.03% in stock price [1] - As of November 13, the stock price reached 19.63 yuan per share, with a total market capitalization of 8.717 billion yuan [1] - The company has seen a net inflow of main funds amounting to 3.6133 million yuan, with large orders contributing significantly to the trading volume [1] Group 2 - Limin Co., Ltd. operates in the basic chemical industry, specifically in agricultural chemical products, including pesticides [2] - The company reported a revenue of 3.599 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 7.62%, while the net profit attributable to shareholders increased by 661.66% to 390 million yuan [2] - The company has a shareholder base of 62,500, which has increased by 12.55% compared to the previous period [2] Group 3 - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919.8 million yuan in dividends, with 321 million yuan distributed over the past three years [3]

Core Viewpoint - Limin Co., Ltd. has experienced significant stock price fluctuations and strong financial performance, with a notable increase in revenue and net profit year-on-year, indicating potential growth in the agricultural chemicals sector [1][2]. Financial Performance - As of October 31, Limin Co., Ltd. achieved a revenue of 3.599 billion yuan for the period from January to September 2025, representing a year-on-year growth of 7.62% [2]. - The company's net profit attributable to shareholders reached 390 million yuan, showing a remarkable increase of 661.66% compared to the previous year [2]. - The company has distributed a total of 919 million yuan in dividends since its A-share listing, with 321 million yuan distributed over the past three years [3]. Stock Market Activity - On November 12, Limin Co., Ltd.'s stock price fell by 2.05% to 18.63 yuan per share, with a trading volume of 33.1959 million yuan and a turnover rate of 0.44%, resulting in a total market capitalization of 8.273 billion yuan [1]. - The stock has increased by 141.23% year-to-date, with a 2.93% rise over the last five trading days, but has seen a decline of 5.43% over the past 20 days and 16.98% over the past 60 days [1]. - The company has appeared on the "Dragon and Tiger List" six times this year, with the most recent occurrence on June 20, where it recorded a net purchase of 24.7786 million yuan [1]. Business Overview - Limin Co., Ltd. is located in Xinyi Economic Development Zone, Jiangsu Province, and was established on December 17, 1996, with its shares listed on January 27, 2015 [1]. - The company's main business involves the research, production, and sales of agricultural fungicides, with revenue composition as follows: fungicides 50.57%, insecticides 30.51%, veterinary drugs 9.34%, herbicides 8.47%, and others 0.96% [1].

Core Viewpoint - Limin Co., Ltd. is a leading enterprise in the domestic fungicide industry, focusing on the research, production, and sales of agricultural fungicide raw materials and formulations, with a full industry chain and technological advantages [1] Group 1: Business Performance - In Q3 2025, Limin's operating revenue reached 3.599 billion yuan, ranking 11th in the industry, lower than the top competitor, Adama Agricultural Solutions, which reported 21.678 billion yuan [2] - The net profit for the same period was 411 million yuan, ranking 7th in the industry, below the leading company, Yangnong Chemical, which had a net profit of 1.056 billion yuan [2] - The main business composition includes agricultural fungicides at 1.24 billion yuan (50.57%), agricultural insecticides at 748 million yuan (30.51%), veterinary drugs at 229 million yuan (9.34%), and agricultural herbicides at 208 million yuan (8.47%) [2] Group 2: Financial Ratios - As of Q3 2025, Limin's debt-to-asset ratio was 45.34%, lower than the previous year's 60.02% and below the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 26.22%, an increase from 18.13% in the previous year and above the industry average of 21.70% [3] Group 3: Executive Compensation - The chairman, Li Xingsheng, received a salary of 1.8526 million yuan in 2024, an increase of 1.1307 million yuan from 2023 [4] - The president, Fan Zhaohui, earned 1.5071 million yuan in 2024, up by 682,200 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 7.91% to 55,500, while the average number of circulating A-shares held per household increased by 9.40% to 7,253.32 [5] - Analysts predict significant growth in net profit for 2025-2027, with estimates of 529 million yuan, 588 million yuan, and 648 million yuan respectively [5]

Core Viewpoint - Limin Co., Ltd. has shown significant stock performance with a year-to-date increase of 148.61%, indicating strong market interest and potential growth in the agricultural chemicals sector [1][2]. Financial Performance - For the first half of 2025, Limin Co., Ltd. achieved a revenue of 2.452 billion yuan, representing a year-on-year growth of 6.69% [2]. - The net profit attributable to shareholders for the same period was 269 million yuan, reflecting a substantial increase of 747.13% year-on-year [2]. Stock Market Activity - On October 29, Limin Co., Ltd. saw its stock price rise by 2.07%, reaching 19.20 yuan per share, with a trading volume of 169 million yuan and a turnover rate of 2.23% [1]. - The company has appeared on the "Dragon and Tiger List" six times this year, with the most recent instance on June 20, where it recorded a net purchase of 24.7786 million yuan [1]. Shareholder Information - As of September 30, the number of shareholders for Limin Co., Ltd. was 55,500, a decrease of 7.91% from the previous period, while the average number of tradable shares per shareholder increased by 9.40% to 7,253 shares [2]. Dividend Distribution - Since its A-share listing, Limin Co., Ltd. has distributed a total of 919 million yuan in dividends, with 321 million yuan distributed over the past three years [3].

Core Viewpoint - Limin Co., Ltd. has experienced a significant stock price increase, with a 5.44% rise on October 13, reaching 20.35 CNY per share, and a cumulative increase of 10.6% over the past five days [1] Group 1: Company Overview - Limin Co., Ltd. is located in Xinyi Economic Development Zone, Jiangsu Province, and was established on December 17, 1996, with its listing date on January 27, 2015 [1] - The company's main business involves the research, production, and sales of agricultural fungicides, with revenue composition as follows: agricultural fungicides 50.57%, agricultural insecticides 30.51%, veterinary drugs 9.34%, agricultural herbicides 8.47%, others 0.96%, and other pesticides 0.15% [1] Group 2: Fund Holdings - Huatai-PineBridge Fund holds a significant position in Limin Co., Ltd., with its Strategic Emerging Industries Mixed A Fund (005409) owning 89,000 shares, accounting for 1.97% of the fund's net value, making it the sixth-largest holding [2] - The fund has realized a floating profit of approximately 93,500 CNY today, with a total floating profit of 164,700 CNY during the five-day price increase [2] Group 3: Fund Manager Performance - The fund manager of Huatai-PineBridge Strategic Emerging Industries Mixed A Fund is Wu Bangdong, who has been in the position for 7 years and 216 days [3] - The total asset size of the fund is 1.329 billion CNY, with the best return during his tenure being 126.03% and the worst return being -25.02% [3]

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has shown significant stock performance with a year-to-date increase of 130.48%, despite recent declines in the last five, twenty, and sixty trading days [1][2] - As of September 26, Limin's stock price reached 17.80 yuan per share, with a market capitalization of 7.85 billion yuan and a trading volume of 1.30 billion yuan [1] - The company has a diverse revenue structure, with agricultural fungicides accounting for 50.57%, insecticides 30.51%, veterinary drugs 9.34%, herbicides 8.47%, and other products making up the remainder [1] Group 2 - Limin Co., Ltd. operates in the basic chemical industry, specifically in agricultural chemical products, and is involved in various concepts such as synthetic biology and bio-pesticides [2] - As of September 10, the number of shareholders increased to 60,300, with an average of 6,630 circulating shares per person [2] - For the first half of 2025, Limin reported a revenue of 2.45 billion yuan, reflecting a year-on-year growth of 6.69%, and a net profit of 269 million yuan, showing a substantial increase of 747.13% [2] Group 3 - Since its A-share listing, Limin has distributed a total of 919 million yuan in dividends, with 321 million yuan distributed over the past three years [3]

Group 1 - The core viewpoint of the news is that Limin Co., Ltd. has experienced a significant decline in stock price, with a drop of 5.1% on September 22, bringing the stock price to 17.67 yuan per share and a total market capitalization of 7.793 billion yuan [1] - Limin Co., Ltd. has seen a cumulative decline of 6.71% over the past three days, indicating a downward trend in its stock performance [1] - The company's main business involves the research, production, and sales of agricultural fungicides, with the revenue composition being 50.57% from agricultural fungicides, 30.51% from insecticides, 9.34% from veterinary drugs, 8.47% from herbicides, and 0.96% from other products [1] Group 2 - From the perspective of fund holdings, Southern Fund has a significant position in Limin Co., Ltd., with its Southern Strategy Optimization Mixed Fund (202019) holding 310,100 shares, representing 2.14% of the fund's net value [2] - The fund has incurred a floating loss of approximately 294,600 yuan today, with a total floating loss of 415,500 yuan during the three-day decline [2] - The Southern Strategy Optimization Mixed Fund (202019) has shown a year-to-date return of 38.54% and a one-year return of 69.32%, ranking 1809 out of 8244 and 1665 out of 8066 respectively [2]

Core Viewpoint - Limin Co., as a leading enterprise in the domestic fungicide industry, is expected to maintain growth in sales of agricultural fungicides and insecticides in the first half of 2025, driven by increased demand in Brazil due to expanded planting areas and frequent disease outbreaks [1] Group 1: Financial Performance - Agricultural fungicides achieved revenue of 1.24 billion yuan in the first half of the year, representing a year-on-year growth of 12.36%, accounting for 50.57% of total revenue [1] Group 2: Market Dynamics - Increased planting area for agricultural products in Brazil and frequent pathogen disasters are driving high demand for fungicides and insecticides [1] Group 3: Strategic Initiatives - The company has successfully obtained independent registrations for five active ingredients in the Brazilian market, including mancozeb, prothioconazole, azoxystrobin, pyraclostrobin, and nicosulfuron [1] - In the domestic market, the company is enhancing regional layout through five differentiated production bases in Jiangsu, Hebei, and Inner Mongolia, which helps reduce production costs and improve price elasticity [1] Group 4: Research and Development - The company has made substantial progress in the research and development of biopesticides, particularly in the application of microbial synthesis technology [1] - Utilizing the Deyan Zhichuang platform, the company has leveraged AI tools to build a computing power platform, data platform, target database, and target resource platform, significantly improving the efficiency of compound development and shortening the screening cycle for new compounds [1] Group 5: Valuation - The current stock price corresponds to price-to-earnings ratios of 23.0, 20.1, and 16.0 times, with a "buy" investment rating assigned [1]

Core Viewpoint - The company reported significant growth in net profit for the first half of 2025, driven by strong sales in its agricultural pesticide business and effective cost management [1][2]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.452 billion yuan, a year-on-year increase of 6.69% [1]. - The net profit attributable to shareholders reached 269 million yuan, reflecting a substantial year-on-year growth of 747.13% [1]. - In Q2 2025, the company recorded operating revenue of 1.241 billion yuan, a year-on-year decline of 5.10% but a quarter-on-quarter increase of 2.52% [1]. Business Segments - The agricultural fungicide segment generated revenue of 1.240 billion yuan in the first half of 2025, up 12.36% year-on-year, accounting for 50.57% of total revenue [2]. - The agricultural insecticide segment reported revenue of 748 million yuan, a year-on-year increase of 5.19%, representing 30.51% of total revenue [2]. - The company expanded its overseas market presence, with international revenue increasing by 22.42%, now comprising 34.57% of total revenue, up 4.44 percentage points from the previous year [2]. Cost Management and Cash Flow - The company maintained stable expenses, with sales, management, financial, and R&D expense ratios showing minor fluctuations [3]. - The net cash flow from operating activities for the first half of 2025 was 91.44 million yuan, a significant year-on-year increase of 180.08%, attributed to rising sales volumes, price increases, and improved gross margins [3]. Innovation and Market Development - The company has made substantial progress in the research and development of biopesticides, particularly in microbial synthesis technology [4]. - Collaborations with agricultural research institutions focus on green pest control technologies, enhancing the integration of AI in pesticide development and agricultural digitalization [4]. - The company has established a synthetic biology laboratory, strengthening its technical capabilities in the biopesticide sector [4]. Profit Forecast - The company forecasts net profits attributable to shareholders of 407 million yuan, 465 million yuan, and 584 million yuan for 2025, 2026, and 2027, respectively [5]. - The expected earnings per share (EPS) for the same years are projected to be 0.92 yuan, 1.05 yuan, and 1.32 yuan, with corresponding price-to-earnings (PE) ratios of 23.0, 20.1, and 16.0 [5].